Navigation Links
Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
Date:1/8/2008

MINNEAPOLIS, Jan. 8 /PRNewswire/ -- Fairview Specialty Pharmacy today announced that it has been selected by BioMarin Pharmaceutical, Inc. to be a participating pharmacy in the specialty pharmacy limited distribution network for Kuvan(TM) (sapropterin dihydrochloride) Tablets, the first specific drug therapy approved for the treatment of phenylketonuria (PKU).

Kuvan was approved by the U.S. Food and Drug Administration (FDA) on December 13 and is now available through Fairview Specialty Pharmacy for patients who are prescribed this treatment by their physicians.

Kari Amundson, Fairview Specialty Pharmacy Director, commented, "We are pleased to be selected by BioMarin to launch this new drug therapy. This distributor agreement is critical to our growth strategy and our ability to provide comprehensive care to patients across the Midwest and at the University of Minnesota Medical Center, Fairview."

"Kuvan is an important breakthrough in the treatment of PKU," said Chester Whitley, Ph.D, M.D., Director of Advanced Therapy Services at the University of Minnesota Medical Center, Fairview. "We are fortunate to have Fairview Specialty Pharmacy as one of the limited specialty distribution providers for this drug."

"We are extremely pleased to be working with specialty pharmacies like Fairview to make this promising new treatment option available to PKU patients and their families," said Stephen Aselage, Senior Vice President of Global Commercial Operations for BioMarin Pharmaceutical.

About Kuvan

Kuvan(TM) (sapropterin dihydrochloride) Tablets is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.

The active ingredient in Kuvan, sapropterin dihydrochloride, is the synthetic form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofa
'/>"/>

SOURCE Fairview Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Specialty Blades, Inc. Completes Acquisition of Popper and Sons, Inc.
2. EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference
3. Heska to Present at New York Society of Security Analysts Biotech/Specialty Pharma Conference
4. Albemarle Raises Prices of Specialty Aluminas
5. Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise
6. Specialty Underwriters Alliance to Present at 2007 FBR Capital Markets Investor Conference
7. Survey shows gender differences are factor when surgeons in training choose a subspecialty
8. Packard Childrens Hospital Opens New South Bay Specialty Clinic Bringing Specialty Care Close to Home
9. Consumer Specialty Products Association Responds to European Study Investigating Spray Products and Asthma
10. Mylan Announces Management of Specialty Business, Dey L.P.
11. Consumer Specialty Products Association Highly Critical of NRDC Study on Home Air Fresheners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... The partners of Urgent Care of Westchester and ... Almendral as their chief provider for advanced beauty treatments. ... opened facility’s plan to offer all of Westchester County ... Almendral is a board certified physician who is trained ... techniques. Her areas of expertise include Botox, Dermal Fillers, ...
(Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will ... honor the strength, passion and endurance of those facing ... of this sunrise-to-sunset event symbolizes the challenging journey of ... raise funds and awareness to advance the care, support ... are encouraged to create their own experience as they ...
(Date:5/28/2015)... Dr. Jenyons’ Medical Weight Loss & Rejuvenation ... looking to undergo its advanced Micro-Needling skin rejuvenating procedure. ... able to get a single Micro-Needling treatment with plasma, ... three-treatment package, which costs $1,800, the clinic will add ... Juanita Jenyons, M.D., says Dr. Jenyons’ Medical Weight Loss ...
(Date:5/28/2015)... 28, 2015 Medelis, Inc., a specialty ... the company in the role of president. , “ Bill ... the CRO industry,” said Larry Flanagan, Medelis’ CEO and co-founder. ... through our next phase of growth.” , Taaffe joined ... from nine employees to over 4,500 employees, achieving 12 consecutive ...
(Date:5/28/2015)... May 28, 2015 Altima Technologies, ... Device Library for documenting and diagramming data center ... for the following product lines: , Manufacturer ... 5500, Chatsworth Products N-Series TeraFrame Cabinet, Middle Atlantic ... Eclipse, Fore Systems ForeRunner, Marantz America MM Series, ...
Breaking Medicine News(10 mins):Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2
... Loosening of Welfare Reform Rules Alter Longstanding System of ... Current versions of both the House and Senate health ... fail to prevent millions of illegal aliens from accessing ... Immigration Reform (FAIR). And in a radical change from ...
... protein implicated in rare form of bowel disorder, researchers ... with painful, chronic bowel conditions such as Crohn,s disease ... from new research. , Scientists say they,ve spotted a ... of colitis, and the finding might have implications for ...
... Inc. (Nasdaq: SGMO ) today reported third quarter 2009 ... ended September 30, 2009, Sangamo reported a consolidated net loss ... consolidated net loss of $6.3 million, or $0.15 per share, ... 2009, the company had cash, cash equivalents, marketable securities and ...
... ), the largest provider of deathcare products and services in North America, today reported results for ... end of this press release. The table below summarizes our key financial results: , , ... ... (In millions, except for September 30, ...
... drug makers, consumers, patients , WEDNESDAY, Nov. 4 (HealthDay ... designed to reduce preventable injuries and deaths caused by ... will focus on preventable injuries and deaths caused by ... attempts at self- harm," Dr. Janet Woodcock, director of ...
... Allergy and Infectious Diseases (NIAID), part of the National ... two programs that support research to better understand the ... including those that may be introduced into a community ... to the Cooperative Centers for Translational Research on Human ...
Cached Medicine News:Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 2Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 3Health News:Gene Discovery Gives Clues to Crohn's Disease, Colitis 2Health News:Gene Discovery Gives Clues to Crohn's Disease, Colitis 3Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 2Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 3Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 4Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 5Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 6Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 7Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 8Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 2Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 3Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 4Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 5Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 6Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 7Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 8Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 9Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 10Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 11Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 12Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 13Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 14Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 15Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 16Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 17Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 18Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 19Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 20Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 21Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 22Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 23Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 24Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 25
(Date:5/28/2015)... May 28, 2015 Zimmer Holdings, Inc. (NYSE ... finalized agreements with buyers to divest in ... Knee System assets, Biomet Discovery® Elbow System assets and ... furtherance of Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... to work constructively with the Bureau of Competition Staff ...
(Date:5/28/2015)... ZURICH , May 28, 2015  Maetrics ( ... the life sciences sector, wrapped up a successful conference, ... the Medical Technology industry," today in Zurich ... ( http://www.maetrics.ch ) and its Switzerland ... regulation on the Medical Technology field to an exclusive ...
(Date:5/28/2015)... YORK , May 28, 2015 ... ( http://www.morcellatorlawsuit2015.com )  in hysterectomies and myomectomies (procedures to ... indicates that the FBI is investigating Johnson & ... largest manufacturer of the devices. According to the ... May 27 th , the FBI is trying ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
... July 25, 2011 A leading international scientist in ... ask their dentists about the potential for cross-contamination in ... that fasten patients, protective bibs in place. ... Dr. John Molinari, Director of Infection Control for ...
... Prasco Laboratories, the Authorized Generics company, announced today it has signed ... the terms of the agreement, Prasco will ... Generic version of Ponstel ® . Prasco ... Prasco label. "With the introduction of the authorized ...
Cached Medicine Technology:Question Your Dentist About Potential for Cross-Contamination, Leading Infection-Control Scientist Tells Fox News 2Prasco® Announces Authorized Generic Agreement with Shionogi Inc. 2
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: